[ Center for Cancer Research ]

Molecular Targets Development Program

Collaborative Research Opportunities


 

The primary focus of MTDP is the collaborative creation, adaptation and use of state-of-the-art biomolecular screening technologies to discover compounds (including non-peptidic, peptidic and proteinaceous compounds) that selectively interact with or modify functions of specific molecular targets (e.g., endogenous molecules, structures, processes or pathways) of priority interest to the CCR, NCI. Tangible products of these efforts include novel or known compounds that may be used as "bioprobes" for target validation research or as drug discovery leads or templates. Accordingly, collaborative research opportunities include the following:

 

© 2000-2005 Center for Cancer Research at the National Cancer Institute.
questions, comments, and suggestions to webmaster
Last modified November 14, 2005


Home | Mission | Organization | News

NCI

Center for Cancer Research
at the
National Cancer Institute

NIH